The global Microarray Biochips market size is predicted to grow from US$ 1385 million in 2025 to US$ 2353 million in 2031; it is expected to grow at a CAGR of 9.2% from 2025 to 2031.
Microarray or biochip is a lab-oriented microscope slide that is usually made of glass, silicon chip, or nylon membrane. It is a 2D array (sometimes 3D) whose surface is provided with thousands of minute pores in defined positions. The microarray is a recently developed technology and was discovered only two decades ago. It is mostly used in cancer research and in the pharmacological treatment of other diseases like oral lesions. It enables researchers to investigate and analyze the expression of thousands of genes in a single reaction and address various issues.
Illumina and Thermo Fisher Scientific are the two largest companies in the industry, accounting for more than 74 percent of 2018 revenue combined. In terms of production value, the United States occupies the absolute position, with production value accounting for more than 86%.
The 鈥淢icroarray Biochips Industry Forecast鈥 looks at past sales and reviews total world Microarray Biochips sales in 2024, providing a comprehensive analysis by region and market sector of projected Microarray Biochips sales for 2025 through 2031. With Microarray Biochips sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Microarray Biochips industry.
This Insight Report provides a comprehensive analysis of the global Microarray Biochips landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Microarray Biochips portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥 unique position in an accelerating global Microarray Biochips market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Microarray Biochips and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Microarray Biochips.
This report presents a comprehensive overview, market shares, and growth opportunities of Microarray Biochips market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
DNA Microarray
Protein Microarray
Other
Segmentation by Application:
Drug Discovery
Research
Diagnostics
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Illumina
Thermo Fisher Scientific
Agilent Technologies
Bio-Rad Laboratories
PerkinElmer
BioChain
Sengenics
Applied Microarrays
US Biomax
Key Questions Addressed in this Report
What is the 10-year outlook for the global Microarray Biochips market?
What factors are driving Microarray Biochips market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Microarray Biochips market opportunities vary by end market size?
How does Microarray Biochips break out by Type, by Application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Microarray Biochips Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Microarray Biochips by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Microarray Biochips by Country/Region, 2020, 2024 & 2031
2.2 Microarray Biochips Segment by Type
2.2.1 DNA Microarray
2.2.2 Protein Microarray
2.2.3 Other
2.3 Microarray Biochips Sales by Type
2.3.1 Global Microarray Biochips Sales 麻豆原创 Share by Type (2020-2025)
2.3.2 Global Microarray Biochips Revenue and 麻豆原创 Share by Type (2020-2025)
2.3.3 Global Microarray Biochips Sale Price by Type (2020-2025)
2.4 Microarray Biochips Segment by Application
2.4.1 Drug Discovery
2.4.2 Research
2.4.3 Diagnostics
2.4.4 Others
2.5 Microarray Biochips Sales by Application
2.5.1 Global Microarray Biochips Sale 麻豆原创 Share by Application (2020-2025)
2.5.2 Global Microarray Biochips Revenue and 麻豆原创 Share by Application (2020-2025)
2.5.3 Global Microarray Biochips Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Microarray Biochips Breakdown Data by Company
3.1.1 Global Microarray Biochips Annual Sales by Company (2020-2025)
3.1.2 Global Microarray Biochips Sales 麻豆原创 Share by Company (2020-2025)
3.2 Global Microarray Biochips Annual Revenue by Company (2020-2025)
3.2.1 Global Microarray Biochips Revenue by Company (2020-2025)
3.2.2 Global Microarray Biochips Revenue 麻豆原创 Share by Company (2020-2025)
3.3 Global Microarray Biochips Sale Price by Company
3.4 Key Manufacturers Microarray Biochips Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Microarray Biochips Product Location Distribution
3.4.2 Players Microarray Biochips Products Offered
3.5 麻豆原创 Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 麻豆原创 M&A Activity & Strategy
4 World Historic Review for Microarray Biochips by Geographic Region
4.1 World Historic Microarray Biochips 麻豆原创 Size by Geographic Region (2020-2025)
4.1.1 Global Microarray Biochips Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Microarray Biochips Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Microarray Biochips 麻豆原创 Size by Country/Region (2020-2025)
4.2.1 Global Microarray Biochips Annual Sales by Country/Region (2020-2025)
4.2.2 Global Microarray Biochips Annual Revenue by Country/Region (2020-2025)
4.3 Americas Microarray Biochips Sales Growth
4.4 APAC Microarray Biochips Sales Growth
4.5 Europe Microarray Biochips Sales Growth
4.6 Middle East & Africa Microarray Biochips Sales Growth
5 Americas
5.1 Americas Microarray Biochips Sales by Country
5.1.1 Americas Microarray Biochips Sales by Country (2020-2025)
5.1.2 Americas Microarray Biochips Revenue by Country (2020-2025)
5.2 Americas Microarray Biochips Sales by Type (2020-2025)
5.3 Americas Microarray Biochips Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Microarray Biochips Sales by Region
6.1.1 APAC Microarray Biochips Sales by Region (2020-2025)
6.1.2 APAC Microarray Biochips Revenue by Region (2020-2025)
6.2 APAC Microarray Biochips Sales by Type (2020-2025)
6.3 APAC Microarray Biochips Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Microarray Biochips by Country
7.1.1 Europe Microarray Biochips Sales by Country (2020-2025)
7.1.2 Europe Microarray Biochips Revenue by Country (2020-2025)
7.2 Europe Microarray Biochips Sales by Type (2020-2025)
7.3 Europe Microarray Biochips Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Microarray Biochips by Country
8.1.1 Middle East & Africa Microarray Biochips Sales by Country (2020-2025)
8.1.2 Middle East & Africa Microarray Biochips Revenue by Country (2020-2025)
8.2 Middle East & Africa Microarray Biochips Sales by Type (2020-2025)
8.3 Middle East & Africa Microarray Biochips Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Microarray Biochips
10.3 Manufacturing Process Analysis of Microarray Biochips
10.4 Industry Chain Structure of Microarray Biochips
11 麻豆原创ing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Microarray Biochips Distributors
11.3 Microarray Biochips Customer
12 World Forecast Review for Microarray Biochips by Geographic Region
12.1 Global Microarray Biochips 麻豆原创 Size Forecast by Region
12.1.1 Global Microarray Biochips Forecast by Region (2026-2031)
12.1.2 Global Microarray Biochips Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Microarray Biochips Forecast by Type (2026-2031)
12.7 Global Microarray Biochips Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Illumina
13.1.1 Illumina Company Information
13.1.2 Illumina Microarray Biochips Product Portfolios and Specifications
13.1.3 Illumina Microarray Biochips Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Illumina Main Business Overview
13.1.5 Illumina Latest Developments
13.2 Thermo Fisher Scientific
13.2.1 Thermo Fisher Scientific Company Information
13.2.2 Thermo Fisher Scientific Microarray Biochips Product Portfolios and Specifications
13.2.3 Thermo Fisher Scientific Microarray Biochips Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Thermo Fisher Scientific Main Business Overview
13.2.5 Thermo Fisher Scientific Latest Developments
13.3 Agilent Technologies
13.3.1 Agilent Technologies Company Information
13.3.2 Agilent Technologies Microarray Biochips Product Portfolios and Specifications
13.3.3 Agilent Technologies Microarray Biochips Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Agilent Technologies Main Business Overview
13.3.5 Agilent Technologies Latest Developments
13.4 Bio-Rad Laboratories
13.4.1 Bio-Rad Laboratories Company Information
13.4.2 Bio-Rad Laboratories Microarray Biochips Product Portfolios and Specifications
13.4.3 Bio-Rad Laboratories Microarray Biochips Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Bio-Rad Laboratories Main Business Overview
13.4.5 Bio-Rad Laboratories Latest Developments
13.5 PerkinElmer
13.5.1 PerkinElmer Company Information
13.5.2 PerkinElmer Microarray Biochips Product Portfolios and Specifications
13.5.3 PerkinElmer Microarray Biochips Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 PerkinElmer Main Business Overview
13.5.5 PerkinElmer Latest Developments
13.6 BioChain
13.6.1 BioChain Company Information
13.6.2 BioChain Microarray Biochips Product Portfolios and Specifications
13.6.3 BioChain Microarray Biochips Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 BioChain Main Business Overview
13.6.5 BioChain Latest Developments
13.7 Sengenics
13.7.1 Sengenics Company Information
13.7.2 Sengenics Microarray Biochips Product Portfolios and Specifications
13.7.3 Sengenics Microarray Biochips Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Sengenics Main Business Overview
13.7.5 Sengenics Latest Developments
13.8 Applied Microarrays
13.8.1 Applied Microarrays Company Information
13.8.2 Applied Microarrays Microarray Biochips Product Portfolios and Specifications
13.8.3 Applied Microarrays Microarray Biochips Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Applied Microarrays Main Business Overview
13.8.5 Applied Microarrays Latest Developments
13.9 US Biomax
13.9.1 US Biomax Company Information
13.9.2 US Biomax Microarray Biochips Product Portfolios and Specifications
13.9.3 US Biomax Microarray Biochips Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 US Biomax Main Business Overview
13.9.5 US Biomax Latest Developments
14 Research Findings and Conclusion
听
听
*If Applicable.